The Food and Drug Administration raised concerns about the potential harm of cannabidiol, or CBD, and marijuana stocks were falling in response on Tuesday.
The FDA said Monday night that it sent warning letters to 15 privately held companies for violations that included marketing unapproved new human and animal drugs, selling CBD products as dietary supplements, and adding CBD to both human and animal foods.
The…